...
首页> 外文期刊>Journal of neurosurgery. >Long-term outcome of endovascular reconstruction with the Pipeline embolization device in the management of unruptured dissecting aneurysms of the intracranial vertebral artery: Clinical article
【24h】

Long-term outcome of endovascular reconstruction with the Pipeline embolization device in the management of unruptured dissecting aneurysms of the intracranial vertebral artery: Clinical article

机译:使用管道栓塞装置进行血管内重建的长期结果可治疗颅内椎动脉的解剖性动脉瘤未破裂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Object. Use of a flow-diverting device has shown promising short-term results in the management of vertebral artery (VA) dissecting aneurysms, but there is still uncertainty regarding its long-term efficacy and safety. The authors report their initial experience with respect to the potential utility and long-term clinical outcomes of using a flow-diverting device in the treatment of unruptured dissecting VA aneurysms. Methods. The authors conducted a retrospective review of all cases of unruptured intracranial VA dissecting aneurysms treated at their institution (Tuen Mun Hospital) with a flow-diverting device. They describe the clinical presentations and angiographic features of the cases and report the clinical outcome (with modified Rankin Scale [mRS] scores) at most recent follow-up, as well as results of the latest angiographic assessment, with particular focus on in-stent patency and side-branch occlusion. Results. A total of 4 aneurysms were successfully obliterated by using flow-diverting devices alone. Two devices were deployed in a telescoping fashion in each of 2 aneurysms, whereas only 1 device was inserted in each of the other 2 aneurysms. No periprocedural complication was encountered. No patient showed any angiographic evidence of recurrence, in-stent thrombosis, or side-branch occlusion in angiographic reassessment at a mean of 22 months after treatment (range 18-24 months). As of the most recent clinical follow-up (mean 30 months after treatment, range 24-37 months), all patients had favorable outcomes (mRS Score 0). Conclusions. Reconstruction using a flow-diverting device is an attractive alternative in definitive treatment of dissecting VA aneurysms, demonstrating favorable long-term clinical and angiographic outcomes and the ability to maintain parent artery and side-branch patency. It is particularly useful in cases with eloquent side-branch or dominant VA involvement.
机译:目的。使用分流装置已显示出在处理椎动脉(VA)夹层动脉瘤的近期有希望的结果,但其长期疗效和安全性仍不确定。作者报告了他们的初步经验,涉及使用分流装置治疗未破裂的解剖性VA动脉瘤的潜在效用和长期临床效果。方法。作者对在其机构(屯门医院)使用分流装置治疗的所有未破裂的颅内VA夹层动脉瘤病例进行了回顾性研究。他们描述了病例的临床表现和血管造影特征,并报告了最近一次随访的临床结局(采用改良的Rankin Scale [mRS]评分),以及最新的血管造影评估结果,特别关注支架内通畅和分支旁闭塞。结果。仅使用分流装置就成功消除了总共4个动脉瘤。在2个动脉瘤的每一个中以伸缩方式部署了两个设备,而在其他2个动脉瘤的每一个中仅插入了1个设备。没有遇到围手术期并发症。在治疗后的平均22个月(18-24个月)内,没有患者在血管造影重新评估中显示出任何复发,支架内血栓形成或分支分支闭塞的血管造影证据。截至最近的临床随访(治疗后30个月,范围24-37个月),所有患者的预后均良好(mRS评分为0)。结论。在确定性解剖VA动脉瘤的最终治疗中,使用分流装置进行重建是一种有吸引力的替代方法,它显示出长期的临床和血管造影良好的结局以及维持父母动脉和侧支通畅的能力。它在雄辩的侧支或支配性VA介入的情况下特别有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号